Results 241 to 250 of about 54,267 (309)

No evidence of molecular markers of piperaquine resistance in southeastern Nigeria. [PDF]

Malar J
Ikegbunam M, Tzirtziganis V, Rodi M, Anagu L, Pessanha de Carvalho L, Inoue J, Held J.   +6 more
europepmc   +1 more source

Identifying antimalarials that disrupt malaria parasite transmission when fed to the mosquito. [PDF]

Int J Parasitol
Farrell SN, Cozijnsen A, Mollard V, Kancharla P, Dodean RA, Kelly JX, McFadden GI, Goodman CD.   +7 more
europepmc   +1 more source

First documented case of imported human babesiosis in Honduras: Diagnostic challenges with malaria falciparum. [PDF]

IJID Reg
Chaver L, Flores H, Padilla W, Rodríguez J, Zúniga C, Medina F, Matamoros G, Araujo ME, Ortiz B, Fontecha G.   +9 more
europepmc   +1 more source

Item-specific factors associated with damage accrual in systemic lupus erythematosus: insights from a multiethnic, multinational Latin American cohort. [PDF]

Lupus Sci Med
Mimica M, Padilla O, Pons-Estel G, Quintana R, Neira O, Catoggio LJ, Saurit V, Drenkard C, Berbotto G, Garcia MA, Borba EF, Bonfá E, Sato EI, de O E Silva AC, Costallat L, Brenol JCT, Vásquez G, Uribe-Uribe O, Iglesias A, Guibert Toledano M, Reyes Llerena G, Pascual-Ramos V, Amigo MC, Barile-Fabris L, García De La Torre I, Acevedo-Vazquez EM, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Alarcon GS, Pons-Estel BA, Ugarte-Gil MF, Massardo L.   +32 more
europepmc   +1 more source

PBPK-Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied Population. [PDF]

CPT Pharmacometrics Syst Pharmacol
Almond LM, Abduljalil K, Pansari A, Kusmider B, Jones HM, Rowland Yeo K, Gardner I, Faisal M, Marrast AC, El Gaaloul M, Möhrle JJ, Abla N.   +11 more
europepmc   +1 more source

Intense Pulsed Light Improves Facial Telangiectasia and Acne-Induced Post-Inflammatory Erythema in Systemic Lupus Erythematosus Patient: A Case Report. [PDF]

J Cosmet Dermatol
Li Z, Lu J, Wu M.
europepmc   +1 more source

Treatment trends of systemic lupus erythematosus from 2007 to 2023 in the USA. [PDF]

Lupus Sci Med
Figueroa-Parra G, Heien HC, Warrington KJ, Shah ND, Crowson CS, McCoy RG, Duarte-García A.   +6 more
europepmc   +1 more source

A case report of telitacicept in the treatment of immunocompromised and refractory lupus nephritis. [PDF]

Front Immunol
Lin Y, Liao C, Yang Z, Zhou T.
europepmc   +1 more source

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022-2023. [PDF]

Malar J
Koko VS, Skrip L, Kumeh O, Washington T, Diallo MO, Kafuko J, Inyang U, Ponce de León GF, Zhou Z, Laird VR, Zawolo J, Getahun B, Harmon-Gray WM, Plucinski M, Schultz JS.   +14 more
europepmc   +1 more source

Efficacy of artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria among children aged 2-11 years in the Asante Akim North Municipality, Ghana: a single-arm open trial. [PDF]

Malar J
Hanson H, Marfo KS, Osei-Mensa J, Jaeger A, Sarpong N, Tsali DN, Martey A, Gyimah AK, Placca E, Oppong M, Foli G, Almoustapha NS, Amuasi J, May J, Maïga Ascofaré O.   +14 more
europepmc   +1 more source